Advertisement
Screener

Apyx Medical Corp (APYX) Revenues

2.8 / 5 stars · 68/120 Roast Me

Apyx Medical Corp Revenues

Apyx Medical Corp (APYX) reported Revenues of $8.29 million for the 3-month period ending 2015-12-31, per its 10-K filed 2016-03-18.

Discontinued › Income Statement › Revenue

us-gaap:Revenues · last filed 2016-03-18

  • Apyx Medical Corp revenues for the quarter ending 2015-12-31 was $8.29M, a 11.10% increase year-over-year.
  • Apyx Medical Corp revenues for the quarter ending 2015-09-30 was $7.82M, a 15.25% increase year-over-year.
  • Apyx Medical Corp revenues for the quarter ending 2015-06-30 was $7.27M, a 4.74% increase year-over-year.
  • Apyx Medical Corp revenues for the quarter ending 2015-03-31 was $6.13M, a 5.46% decline year-over-year.
Period endRevenues 3 monthRevenues 6 monthRevenues 9 monthRevenues 12 month
2015-12-31$8.29M
10-K · filed 2016-03-18
$16.12M
derived: sum of 2 quarters · filed 2016-03-18
$23.39M
derived: sum of 3 quarters · filed 2016-03-18
$29.52M
derived: sum of 4 quarters · filed 2016-03-18
2015-09-30$7.82M
10-K · filed 2016-03-18
$15.10M
derived: sum of 2 quarters · filed 2016-03-18
$21.23M
derived: sum of 3 quarters · filed 2016-03-18
$28.69M
derived: sum of 4 quarters · filed 2016-03-18
2015-06-30$7.27M
10-K · filed 2016-03-18
$13.40M
derived: sum of 2 quarters · filed 2016-03-18
$20.87M
derived: sum of 3 quarters · filed 2016-03-18
$27.66M
derived: sum of 4 quarters · filed 2016-03-18
2015-03-31$6.13M
10-K · filed 2016-03-18
$13.59M
derived: sum of 2 quarters · filed 2016-03-18
$20.38M
derived: sum of 3 quarters · filed 2016-03-18
$27.33M
derived: sum of 4 quarters · filed 2016-03-18
2014-12-31$7.47M
10-K · filed 2016-03-18
$14.25M
derived: sum of 2 quarters · filed 2016-03-18
$21.20M
derived: sum of 3 quarters · filed 2016-03-18
$27.68M
derived: sum of 4 quarters · filed 2016-03-18
2014-09-30$6.79M
10-K · filed 2016-03-18
$13.73M
derived: sum of 2 quarters · filed 2016-03-18
$20.21M
derived: sum of 3 quarters · filed 2016-03-18
$26.34M
derived: sum of 4 quarters · filed 2016-03-18
2014-06-30$6.95M
10-K · filed 2016-03-18
$13.43M
derived: sum of 2 quarters · filed 2016-03-18
$19.55M
derived: sum of 3 quarters · filed 2016-03-18
$25.35M
derived: sum of 4 quarters · filed 2016-03-18
2014-03-31$6.48M
10-K · filed 2016-03-18
$12.61M
derived: sum of 2 quarters · filed 2016-03-18
$18.40M
derived: sum of 3 quarters · filed 2016-03-18
$24.45M
derived: sum of 4 quarters · filed 2016-03-18
2013-12-31$6.13M
10-K · filed 2015-02-27
$11.92M
derived: sum of 2 quarters · filed 2015-02-27
$17.96M
derived: sum of 3 quarters · filed 2015-02-27
$23.66M
derived: sum of 4 quarters · filed 2015-02-27
2013-09-30$5.79M
10-K · filed 2015-02-27
$11.84M
derived: sum of 2 quarters · filed 2015-02-27
$17.53M
derived: sum of 3 quarters · filed 2015-02-27
2013-06-30$6.04M
10-K · filed 2015-02-27
$11.74M
derived: sum of 2 quarters · filed 2015-02-27
2013-03-31$5.70M
10-K · filed 2015-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Microbot Medical Inc. (MBOT)$0.089B-7.97
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
LENSAR, Inc. (LNSR)United States$0.087B2.02
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
Pulmonx Corp (LUNG)United States$0.082B-1.16
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
Lucid Diagnostics Inc. (LUCD)United States$0.170B
CVRx, Inc. (CVRX)United States$0.067B-2.62
DarioHealth Corp. (DRIO)$0.066B-1.39